63 results
424B3
CTCX
Carmell Therapeutics Corporation
16 Aug 24
Prospectus supplement
9:27am
(Unaudited)
NOTE 1 — NATURE OF THE ORGANIZATION AND BUSINESS
Unless the context requires otherwise, references to “Carmell,” or the “Company” prior … . The accompanying unaudited condensed consolidated financial statements include all adjustments that are of a normal recurring nature and necessary
424B3
CTCX
Carmell Therapeutics Corporation
5 Jun 24
Prospectus supplement
6:06am
with the aesthetic results of our cosmetic products. Our products are cosmetic in nature and the success of the results are highly subjective. Accordingly, cosmetics … or other technology, whether in the nature of trade secrets, copyrights, patents or other rights. CMU has the right to use such intellectual property
D
vuopz
30 Apr 24
$3.00 mm in equity, sold $3.00 mm, 19 investors
10:36am
8-K
EX-10.1
2khqha1tr gdxvt6pz
4 Apr 24
Carmell Announces $3.0 Million Private Placement
5:28pm
8-K
EX-10.2
8dyxgl 8ph69
4 Apr 24
Carmell Announces $3.0 Million Private Placement
5:28pm
8-K
EX-10.1
3w3wb1vu
25 Mar 24
Entry into a Material Definitive Agreement
8:46pm
8-K/A
EX-99.3
qno7cxum2bd9p3p ck
25 Oct 23
Unaudited Condensed Financial Statements
4:02pm
8-K/A
EX-99.1
e5k7o15hraffk5v
25 Oct 23
Unaudited Condensed Financial Statements
4:02pm
8-K/A
EX-99.2
4b4169lrmn9kv061p9c
25 Oct 23
Unaudited Condensed Financial Statements
4:02pm
8-K/A
EX-99.1
lyoebmac9vhlzjlo ve
14 Aug 23
Completion of Acquisition or Disposition of Assets
5:55pm
8-K/A
EX-99.3
o7902q4ltbskqdmu
14 Aug 23
Completion of Acquisition or Disposition of Assets
5:55pm